| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |